Request Demo
Last update 23 Jan 2025
Suzhou Yasheng Pharmaceutical Co., Ltd.
Private Company|
2016|
Jiangsu Sheng, China
Last update 23 Jan 2025
Overview
Tags
Neoplasms
Immune System Diseases
Urogenital Diseases
Small molecule drug
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20243842
奥雷巴替尼治疗SDH缺陷型胃肠道间质瘤的单臂关键性注册Ⅲ期临床研究（POLARIS-3）
[Translation] A single-arm pivotal registration phase III clinical study of orebactinib in the treatment of SDH-deficient gastrointestinal stromal tumors (POLARIS-3)
NCT06182969
A Randomized, Double-blind, Placebo-controlled Phase I/II Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of APG-2575 in Patients with Mild-to-moderate Systemic Lupus Erythematosus.
CTR20233944
评估APG-2575在轻中度系统性红斑狼疮患者中的安全性、药代动力学和药效动力学的随机，双盲，安慰剂对照Ⅰb/Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase Ib/II clinical study to evaluate the safety, pharmacokinetics and pharmacodynamics of APG-2575 in patients with mild to moderate systemic lupus erythematosus
100 Clinical Results associated with Suzhou Yasheng Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Suzhou Yasheng Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Yasheng Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
2
Phase 1 Clinical
Phase 2 Clinical
3
1
NDA/BLA
Approved
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free